IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 197 filers reported holding IMPAX LABORATORIES INC in Q2 2015. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $5,492,000 | – | 117,180 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |